378 related articles for article (PubMed ID: 14673473)
21. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.
Almeida MR; Alves IL; Terazaki H; Ando Y; Saraiva MJ
Biochem Biophys Res Commun; 2000 Apr; 270(3):1024-8. PubMed ID: 10772944
[TBL] [Abstract][Full Text] [Related]
22. [A late onset familial amyloidotic polyneuropathy (FAP) with a novel variant transthyretin characterized by a basic-for-acidic amino acid substitution (Glu61-->Lys)].
Yamamoto T; Matsunaga K; Ohnishi A; Nakazato M; Murai Y
Rinsho Shinkeigaku; 1996 Sep; 36(9):1065-8. PubMed ID: 8976129
[TBL] [Abstract][Full Text] [Related]
23. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
25. [Protein and DNA sequencing analyses of transthyretin in familial amyloidotic polyneuropathy].
Nakazato M
Rinsho Shinkeigaku; 1995 Dec; 35(12):1436-7. PubMed ID: 8752422
[TBL] [Abstract][Full Text] [Related]
26. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
27. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
[TBL] [Abstract][Full Text] [Related]
28. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
[TBL] [Abstract][Full Text] [Related]
29. Familial amyloid polyneuropathy associated with TTRSer50Arg mutation in two Iberian families presenting a novel single base change in the mutant gene.
Munar-Qués M; Masjuan J; Coelho T; Moreira P; Viader-Farré C; Saraiva MJ
Amyloid; 2007 Jun; 14(2):147-52. PubMed ID: 17577688
[TBL] [Abstract][Full Text] [Related]
30. Screening and biochemical characterization of transthyretin variants in the Portuguese population.
Alves IL; Altland K; Almeida MR; Winter P; Saraiva MJ
Hum Mutat; 1997; 9(3):226-33. PubMed ID: 9090525
[TBL] [Abstract][Full Text] [Related]
31. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
[TBL] [Abstract][Full Text] [Related]
32. Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55-->Pro).
Yamamoto K; Hsu SP; Yoshida K; Ikeda S; Nakazato M; Shiomi K; Cheng SY; Furihata K; Ueno I; Yanagisawa N
Muscle Nerve; 1994 Jun; 17(6):637-41. PubMed ID: 7910950
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Mariani LL; Lozeron P; Théaudin M; Mincheva Z; Signate A; Ducot B; Algalarrondo V; Denier C; Adam C; Nicolas G; Samuel D; Slama MS; Lacroix C; Misrahi M; Adams D;
Ann Neurol; 2015 Dec; 78(6):901-16. PubMed ID: 26369527
[TBL] [Abstract][Full Text] [Related]
34. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
35. Transthyretin: no association between serum levels or gene variants and schizophrenia.
Ruano D; Macedo A; Soares MJ; Valente J; Azevedo MH; Hutz MH; Gama CS; Lobato MI; Belmonte-de-Abreu P; Goodman AB; Pato C; Saraiva MJ; Heutink P; Palha JA
J Psychiatr Res; 2007 Oct; 41(8):667-72. PubMed ID: 16716350
[TBL] [Abstract][Full Text] [Related]
36. Familial amyloid polyneuropathy in Korea: the first case report with a proven ATTR Lys35Asn gene.
Ryu JK; Baik HW; Bae JS; Hwang TJ; Paik SY; Yu HJ; Choi BO; Takei Y; Ikeda S
Amyloid; 2005 Mar; 12(1):62-4. PubMed ID: 16076613
[TBL] [Abstract][Full Text] [Related]
37. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
Obayashi K; Tasaki M; Jono H; Ueda M; Shinriki S; Misumi Y; Yamashita T; Oshima T; Nakamura T; Ikemizu S; Anan I; Suhr O; Ando Y
Clin Chim Acta; 2013 Apr; 419():127-31. PubMed ID: 23462670
[TBL] [Abstract][Full Text] [Related]
38. Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins.
Holmgren G; Wikström L; Lundgren HE; Suhr OB
J Intern Med; 2004 Nov; 256(5):453-6. PubMed ID: 15485482
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
[TBL] [Abstract][Full Text] [Related]
40. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)].
Nakamura M; Ando Y
Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
